RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $123,130,717.20

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$190.95

▼ -5.99 (-3.04%)

As of 09/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/16/2026	Alan B Sandler	Insider	Sell	341	$199.24	$67,940.84	52,868
9/16/2026	Jack Anders	CFO	Sell	4,053	$199.24	$807,519.72	119,216
9/16/2026	Margaret A. Horn	COO	Sell	4,967	$199.24	$989,625.08	149,680
9/16/2026	Mark A. Goldsmith	Insider	Sell	13,988	$199.24	$2,786,969.12	253,342
9/16/2026	Stephen Michael Kelsey	Insider	Sell	5,569	$199.24	$1,109,567.56	286,307
9/11/2026	Stephen Michael Kelsey	Insider	Sell	92,531	$202.36	$18,724,573.16	291,876
9/8/2026	Lorence H. Kim	Director	Sell	17,090	$209.82	$3,585,823.80
8/31/2026	Lorence H. Kim	Director	Sell	56,000	$203.24	$11,381,440.00	17,090
8/21/2026	Mark A. Goldsmith	Insider	Sell	80,000	$209.20	$16,736,000.00	267,330
6/29/2026	Sushil Patel	Director	Sell	5,580	$187.99	$1,048,984.20	21,656
6/24/2026	Jack Anders	CFO	Sell	20,000	$168.33	$3,366,600.00	123,269
6/17/2026	Margaret A. Horn	COO	Sell	29,600	$160.12	$4,739,552.00	154,647
6/16/2026	Jack Anders	CFO	Sell	2,722	$156.12	$424,958.64	123,269
6/16/2026	Mark A. Goldsmith	Insider	Sell	10,020	$156.12	$1,564,322.40	267,330
6/16/2026	Stephen Michael Kelsey	Insider	Sell	4,175	$156.12	$651,801.00	291,876
6/15/2026	Margaret A. Horn	COO	Sell	60,400	$160.17	$9,674,268.00	158,222
4/15/2026	Mark A. Goldsmith	Insider	Sell	120,000	$150.09	$18,010,800.00	276,698
3/17/2026	Jack Anders	CFO	Sell	2,753	$99.48	$273,868.44	125,512
3/17/2026	Lin Wei	Insider	Sell	2,073	$99.48	$206,222.04	101,366
3/17/2026	Margaret A. Horn	COO	Sell	4,583	$99.48	$455,916.84	157,570
3/17/2026	Mark A. Goldsmith	Insider	Sell	12,871	$99.48	$1,280,407.08	276,698
3/17/2026	Stephen Michael Kelsey	Insider	Sell	4,302	$99.48	$427,962.96	295,398
3/17/2026	Xiaolin Wang	Insider	Sell	2,010	$99.48	$199,954.80	116,063
3/2/2026	Mark A. Goldsmith	Insider	Sell	30,000	$101.22	$3,036,600.00	289,569
3/2/2026	Mark A. Goldsmith	Insider	Sell	6,000	$101.30	$607,800.00	64,424
1/7/2026	Jack Anders	CFO	Sell	10,000	$98.00	$980,000.00	108,065
1/7/2026	Margaret A. Horn	COO	Sell	75,000	$100.56	$7,542,000.00	141,053
12/16/2025	Jack Anders	CFO	Sell	3,104	$77.09	$239,287.36	108,065
12/16/2025	Margaret A. Horn	COO	Sell	4,847	$76.82	$372,346.54	141,053
12/16/2025	Mark A. Goldsmith	Insider	Sell	15,394	$76.82	$1,182,567.08	232,469
12/16/2025	Stephen Michael Kelsey	Insider	Sell	5,447	$76.82	$418,438.54	278,600
11/25/2025	Mark A. Goldsmith	Insider	Sell	60,000	$75.08	$4,504,800.00	247,863
11/18/2025	Mark A. Goldsmith	Insider	Sell	20,000	$70.38	$1,407,600.00	247,863
11/12/2025	Mark A. Goldsmith	Insider	Sell	20,000	$65.07	$1,301,400.00	247,863
11/7/2025	Mark A. Goldsmith	Insider	Sell	30,000	$60.31	$1,809,300.00	347,863
10/13/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$48.54	$1,213,500.00	284,047
9/16/2025	Jack Anders	CFO	Sell	2,320	$45.82	$106,302.40	110,994
9/16/2025	Lin Wei	Insider	Sell	2,160	$45.82	$98,971.20	88,339
9/16/2025	Margaret A. Horn	COO	Sell	4,775	$45.82	$218,790.50	145,900
9/16/2025	Mark A. Goldsmith	Insider	Sell	13,411	$45.82	$614,492.02	452,309
9/16/2025	Stephen Michael Kelsey	Insider	Sell	5,367	$45.82	$245,915.94	284,047
9/15/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$45.97	$1,149,250.00	289,414
9/11/2025	Stephen Michael Kelsey	Insider	Sell	100,000	$44.08	$4,408,000.00	289,414
9/3/2025	Jack Anders	CFO	Sell	5,238	$40.17	$210,410.46	113,314
9/2/2025	Jack Anders	CFO	Sell	4,762	$40.02	$190,575.24	113,314
6/16/2025	Margaret A. Horn	COO	Sell	3,575	$156.12	$558,129.00	154,647
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/10/2026	ABS Direct Equity Fund LLC	187	$35K	0.0%	-89.6%	0.000%
9/9/2026	Sequoia Financial Advisors LLC	3,342	$0.63M	0.0%	N/A	0.002%
9/9/2026	Tidal Investments LLC	109,096	$20.43M	0.0%	-20.5%	0.051%
9/9/2026	MCF Advisors LLC	415	$78K	0.0%	N/A	0.000%
9/9/2026	National Pension Service	273,604	$51.24M	0.0%	N/A	0.128%
9/9/2026	Engineers Gate Manager LP	7,380	$1.38M	0.0%	+144.0%	0.003%
9/9/2026	Integrated Wealth Concepts LLC	1,485	$0.28M	0.0%	N/A	0.001%
9/9/2026	NewEdge Advisors LLC	2,806	$0.53M	0.0%	N/A	0.001%
9/9/2026	IFP Advisors Inc	745	$0.14M	0.0%	+577.3%	0.000%
9/8/2026	Hudock Inc.	1,470	$0.28M	0.0%	N/A	0.001%
9/8/2026	Allworth Financial LP	2,240	$0.42M	0.0%	+227.5%	0.001%
9/8/2026	Arizona State Retirement System	46,382	$8.69M	0.0%	+17.7%	0.022%
9/8/2026	Waverly Advisors LLC	1,484	$0.28M	0.0%	N/A	0.001%
9/8/2026	Paragon Capital Management Ltd	1,124	$0.21M	0.0%	N/A	0.001%
9/8/2026	Nykredit A S	44,928	$8.41M	0.0%	N/A	0.021%
8/27/2026	Corient Private Wealth LP	10,537	$1.97M	0.0%	+5.9%	0.005%
8/26/2026	HighTower Advisors LLC	10,485	$1.96M	0.0%	+311.2%	0.005%
8/23/2026	Washington Trust Advisors Inc.	482	$90K	0.0%	N/A	0.000%
8/23/2026	Readystate Asset Management LP	37,727	$7.07M	0.2%	+18.5%	0.018%
8/23/2026	Ameritas Advisory Services LLC	256	$48K	0.0%	N/A	0.000%
8/23/2026	Wedmont Private Capital	40,281	$7.53M	0.2%	+0.1%	0.019%
8/23/2026	HB Wealth Management LLC	5,336	$1M	0.0%	+71.6%	0.002%
8/23/2026	Saudi Central Bank	11,324	$2.12M	0.0%	+111.6%	0.005%
8/22/2026	William John Sempolinski	1,850	$0.35M	0.1%	N/A	0.001%
8/22/2026	Three Seasons Wealth LLC	1,765	$0.33M	0.0%	N/A	0.001%
8/22/2026	Washington Growth Strategies LLC	1,317	$0.25M	0.1%	N/A	0.001%
8/22/2026	Raiffeisen Bank International AG	20,101	$3.87M	0.0%	-22.7%	0.009%
8/22/2026	Concurrent Investment Advisors LLC	2,534	$0.48M	0.0%	N/A	0.001%
8/21/2026	High Net Worth Advisory Group LLC	2,000	$0.38M	0.1%	N/A	0.001%
8/21/2026	Nykredit A S	52,663	$9.86M	0.0%	N/A	0.025%
8/21/2026	B. Metzler seel. Sohn & Co. AG	13,605	$2.55M	0.0%	+12.8%	0.006%
8/20/2026	Moore Capital Management LP	81,700	$15.30M	0.2%	+46.9%	0.038%
8/20/2026	GTS Securities LLC	1,151	$0.22M	0.0%	N/A	0.001%
8/20/2026	Alyeska Investment Group L.P.	659,279	$123.47M	0.3%	-65.0%	0.308%
8/20/2026	Jasper Ridge Partners L.P.	5,809	$1.09M	0.0%	-59.6%	0.003%
8/20/2026	Harvest Management LLC	7,221	$1.35M	0.5%	-9,601.3%	0.003%
8/20/2026	Northwestern Mutual Wealth Management Co.	218	$41K	0.0%	+147.7%	0.000%
8/20/2026	Wedbush Securities Inc.	1,548	$0.29M	0.0%	N/A	0.001%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	912,335	$170.86M	0.0%	+82.3%	0.426%
8/19/2026	Royal London Asset Management Ltd.	3,808	$0.71M	0.0%	+21.2%	0.002%
8/19/2026	Van ECK Associates Corp	111,381	$20.86M	0.0%	+1.8%	0.052%
8/19/2026	Nissay Asset Management Corp Japan	21,164	$3.96M	0.0%	+14.9%	0.010%
8/19/2026	Hsbc Holdings PLC	71,816	$13.46M	0.0%	+119.0%	0.034%
8/19/2026	Wellington Management Group LLP	3,843,415	$719.80M	0.1%	-36.2%	1.793%
8/18/2026	Beacon Pointe Advisors LLC	1,850	$0.35M	0.0%	N/A	0.001%
8/18/2026	Livforsakringsbolaget Skandia Omsesidigt	1,000	$0.19M	0.0%	N/A	0.000%
8/18/2026	Empowered Funds LLC	52,086	$9.76M	0.1%	N/A	0.024%
8/18/2026	United Capital Financial Advisors LLC	3,175	$0.60M	0.0%	N/A	0.001%
8/18/2026	Equitable Holdings Inc.	5,140	$0.96M	0.0%	N/A	0.002%
8/18/2026	Public Employees Retirement System of Ohio	77,402	$14.50M	0.0%	N/A	0.036%
8/17/2026	Capstone Investment Advisors LLC	7,200	$1.35M	0.0%	N/A	0.003%
8/17/2026	Seven Fleet Capital Management LP	242,029	$45.33M	7.5%	+199.6%	0.113%
8/17/2026	Corient Private Wealth LP	8,137	$1.52M	0.0%	N/A	0.004%
8/17/2026	Artia Global Partners LP	185,390	$34.72M	6.4%	N/A	0.086%
8/17/2026	Bamco Inc. NY	12,500	$2.34M	0.0%	N/A	0.006%
8/17/2026	Bank of America Corp DE	983,911	$184.27M	0.0%	N/A	0.459%
8/15/2026	Freestone Grove Partners LP	64,813	$12.14M	0.1%	N/A	0.030%
8/15/2026	Caisse de depot et placement du Quebec	3,066	$0.57M	0.0%	N/A	0.001%
8/15/2026	Trails Edge Capital Partners LP	115,750	$21.68M	0.0%	N/A	0.054%
8/15/2026	ABS Investment Management LLC	187	$337.10M	0.2%	N/A	0.000%
8/14/2026	ADAR1 Capital Management LLC	87,509	$16.39M	0.8%	N/A	0.041%
8/14/2026	Hsbc Holdings PLC	71,816	$13.46M	0.0%	N/A	0.034%
8/14/2026	Legal & General Group Plc	381,366	$71.42M	0.0%	N/A	0.178%
8/14/2026	The Manufacturers Life Insurance Company	58,991	$11.05M	0.0%	N/A	0.028%
8/14/2026	L2 Asset Management LLC	1,147	$0.22M	0.0%	N/A	0.001%
8/14/2026	Nan Fung Group Holdings Ltd	19,253	$3.61M	0.0%	N/A	0.009%
8/13/2026	Cibc World Market Inc.	14,093	$2.64M	0.0%	N/A	0.007%
8/13/2026	OMERS ADMINISTRATION Corp	2,308	$0.43M	0.0%	N/A	0.001%
8/13/2026	Osmosis Investment Management UK Ltd	3,447	$0.65M	0.0%	N/A	0.002%
8/13/2026	Sanctuary Advisors LLC	6,534	$1.22M	0.0%	N/A	0.003%
8/13/2026	Bank of Nova Scotia	73,879	$13.84M	0.0%	N/A	0.034%
8/12/2026	Daiichi Life Insurance Co. Ltd.	5,523	$1.03M	0.0%	N/A	0.003%
8/12/2026	Commerce Bank	1,443	$0.27M	0.0%	N/A	0.001%
8/12/2026	Northwestern Mutual Wealth Management Co.	218	$41K	0.0%	N/A	0.000%
8/12/2026	Quantbot Technologies LP	5,724	$1.07M	0.0%	N/A	0.003%
8/12/2026	Korea Investment CORP	60,100	$11.26M	0.0%	N/A	0.028%
8/12/2026	Rakuten Securities Inc.	350	$66K	0.0%	N/A	0.000%
8/12/2026	Ieq Capital LLC	58,834	$11.02M	0.1%	N/A	0.027%
8/11/2026	Allworth Financial LP	2,240	$0.42M	0.0%	N/A	0.001%
8/11/2026	B. Metzler seel. Sohn & Co. AG	13,605	$2.55M	0.0%	N/A	0.006%
8/11/2026	Silvant Capital Management LLC	220	$41K	0.0%	N/A	0.000%
8/11/2026	Vise Technologies Inc.	2,593	$0.49M	0.0%	N/A	0.001%
8/11/2026	E Fund Management Co. Ltd.	2,907	$0.54M	0.0%	N/A	0.001%
8/10/2026	Johnson Financial Group Inc.	200	$37K	0.0%	N/A	0.000%
8/10/2026	Eagle Health Investments LP	120,346	$22.54M	3.7%	N/A	0.056%
8/10/2026	Danske Bank A S	79,200	$14.83M	0.0%	N/A	0.037%
8/8/2026	Wealthfront Advisers LLC	1,710	$0.32M	0.0%	N/A	0.001%
8/8/2026	Meeder Advisory Services Inc.	3,922	$0.74M	0.0%	N/A	0.002%
8/7/2026	Citizens Financial Group Inc. RI	74,036	$13.87M	0.2%	N/A	0.035%
8/7/2026	Deutsche Bank AG	888,019	$166.31M	0.0%	N/A	0.418%
8/7/2026	Alphabet Inc.	2,946,619	$551.84M	0.6%	N/A	1.386%
8/7/2026	Mitsubishi UFJ Asset Management Co. Ltd.	186,924	$35.01M	0.0%	N/A	0.088%
8/7/2026	Persistent Asset Partners Ltd	38,726	$7.25M	2.2%	N/A	0.018%
8/7/2026	AMG National Trust Bank	1,617	$0.30M	0.0%	N/A	0.001%
8/6/2026	Global Retirement Partners LLC	1,310	$0.25M	0.0%	N/A	0.001%
8/6/2026	SCS Capital Management LLC	3,867	$0.72M	0.0%	N/A	0.002%
8/6/2026	Bank of New York Mellon Corp	601,056	$112.57M	0.0%	N/A	0.283%
8/6/2026	Centric Wealth Management	3,416	$0.51M	0.1%	N/A	0.002%
8/6/2026	Focus Partners Advisor Solutions LLC	1,631	$0.31M	0.0%	N/A	0.001%
8/6/2026	State of Wyoming	9,446	$1.77M	0.2%	N/A	0.004%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $190.95

$188.18

$197.10

50 Day Range

MA: $199.57

$179.18

$221.15

52 Week Range

Now: $190.95

$42.18

$224.31

Volume

5,937,950 shs

Average Volume

1,732,172 shs

Market Capitalization

$40.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Rock Ventures Iii LP Third (Major Shareholder)
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Margaret A Horn (Insider)
Lorence H Kim (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Wellington Management Group LLP — 1.79%
Alphabet Inc. — 1.39%
Bank of America Corp DE — 0.46%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.43%
Deutsche Bank AG — 0.42%
Alyeska Investment Group L.P. — 0.31%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Wellington Management Group LLP
Alyeska Investment Group L.P.
Tidal Investments LLC
Tema ETFs LLC
Jasper Ridge Partners L.P.
Raiffeisen Bank International AG
ABS Direct Equity Fund LLC
Avior Wealth Management LLC
In the last year, company insiders that have sold Revolution Medicines company stock include:
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Xiaolin Wang (Insider)
Lin Wei (Insider)
Alan B Sandler (Insider)
Sushil Patel (Director)
Lorence H Kim (Director)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
Alphabet Inc.
Bank of America Corp DE
Deutsche Bank AG
Bank of New York Mellon Corp
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Legal & General Group Plc
National Pension Service
Assenagon Asset Management S.A.